Related by context. All words. (Click for frequent words.) 69 Intervention Trial GAIT 69 Alzheimer Disease Cooperative 65 Immune Tolerance Network 64 Intervention Effectiveness 63 Clinical Antipsychotic Trials 62 CALGB 62 Arthritis Musculoskeletal 62 DAPT Study 62 Clinical Trials Unit 62 Glucosamine chondroitin Arthritis 62 NGFN 61 NCCTG 61 Ovarian PLCO Cancer 61 multicenter phase 61 number NCT# ClinicalTrials.gov 61 GELA 61 Gynecologic Oncology Group 61 Alzheimer Disease Genetics 60 NHGRI Division 60 placebo controlled Phase III 60 Group RTOG 60 Consortium ICGC 60 Translational Science Award 60 NCIC Clinical Trials 60 Multicentre 60 ENESTnd 60 Prostate Lung Colorectal 59 ONTARGET 59 Current Controlled Trials 59 DF HCC 59 cardio renal 59 MassGeneral Institute 59 NABTT 59 KLRI 59 AIDS Clinical Trials 59 Neurological Diseases 59 Intervention Effectiveness CATIE 59 Autism Consortium 59 ADVANCE PD 59 AIR2 Trial 59 EXPLORE Xa 59 EnVivo Pharmaceuticals 59 Radiation Therapy Oncology 59 Trandolapril 59 Musculoskeletal Diseases 59 Neurodegenerative Diseases 59 Centers Helmholtz Gemeinschaft 59 Glucosamine Chondroitin Arthritis 59 Phase Ib IIa 59 Pharmacopeial Convention 59 Bundesministerium für Bildung und 59 CHAMPION PCI 59 Cholesterol Levels SPARCL 58 Intervention Trial 58 High Throughput Biology 58 Neurotherapeutics 58 Cellular Therapies 58 CMCR 58 Ovarian Cancer Screening 58 Phase Ib II 58 LUMINATE 58 SWOG 58 Tumor Microenvironment 58 Investigator Initiated 58 Dementias 58 Phase III multicenter 58 Neurodegenerative Disease 58 Alzheimer Disease Neuroimaging Initiative 58 Evaluation Program CTEP 58 CLARITY TIMI 58 CHARISMA trial 58 Evaluation WISE 58 PGRN 58 Patient Registry 58 Multiethnic Study 58 Joslin Diabetes 58 CAPRIE 58 phase IIIb 58 prospective nonrandomized 58 Gastrointestinal Oncology 58 Left Ventricular Dysfunction 58 multicenter randomized clinical 57 Research Programs CDMRP 57 Reproductive Genetics 57 Max Neeman International 57 Atherosclerosis MESA 57 Tuberculosis Vaccine 57 Phase Ib clinical 57 Anticancer Agents 57 ThermoDox ® clinical 57 Neuroepidemiology 57 WAIMR 57 EDRN 57 YONDELIS 57 BioNumerik 57 double blinded randomized 57 TG MV 57 Acute Stroke 57 NCI Cancer 57 Autism Genome Project 57 Oral Fingolimod 57 Human Hookworm Vaccine Initiative 57 pivotal bioequivalence 57 rALLy clinical trial 57 Biomarker Study 57 DEcIDE 57 Pediatric Oncology Branch 57 International Verapamil SR 57 BCIRG 57 WHO TDR 57 Acute Liver Failure 57 Neuropharmacology 57 Neurologic Disorders 57 INSPIRE Trial Phase III 57 Women Ischemia Syndrome 57 Renal Cancer 57 Ceflatonin R 57 Systemic Sclerosis 57 Institute DCRI 56 TREAT ALS 56 KGK Synergize Inc. 56 Avidex 56 Aggressive Reduction 56 Autoimmune Disease 56 Leon Benoziyo Center 56 Clinical Trial Investigating REOLYSIN 56 Translational Science Awards 56 Intramural Research 56 EchoCRT 56 Prostate Cancer Clinical Trial 56 phase Ib clinical 56 MMRC Member 56 Novel Therapeutics 56 Adult Stem Cell Therapy 56 OLYMPIA registry 56 Duke Translational Medicine 56 Group NCIC CTG 56 Multicenter 56 Post Doctoral Fellowship 56 Combination REOLYSIN R 56 HPTN 56 Toxicogenomics 56 Genetic Epidemiology 56 Agios Pharmaceuticals 56 Spine Patient Outcomes 56 PRESEPT 56 Asthma COPD 56 REVIVE Diabetes 56 SANTE 56 Ridaforolimus 56 Initiates Clinical Trial 56 Stroke NINDS 56 Clinical Trials Consortium 56 Shiley Marcos Alzheimer Disease 56 Dialysis Outcomes 56 Am J Geriatr 56 #:#-#,# CrossRef Medline [002] 56 IIa clinical 56 Behavioral Neurobiology 56 NIDCR 56 ACRIN 56 BZA CE 56 TMC# C# 56 Prospective Randomized 56 Gastric Cancer 56 #:#-#,# CrossRef Medline [001] 56 YONDELIS R 56 Systemic Lupus Erythematosus SLE 56 FoldRx Pharmaceuticals Inc. 56 Screening Trial 56 Investigative Pathology 56 CIBMTR 56 Diabetes Endocrinology 56 Clinical Outcome 56 Delcath Phase III 56 Survivorship Program 56 ECASS 56 Cellular Therapy 56 RhuDex 56 Tjeerdema chairs 56 Asthma Intervention 56 Metabolomics 56 Nonalcoholic Steatohepatitis 56 LSRO 56 HNRCA 56 CAMMS# 56 dbGaP 56 Oncologic 56 Genetics Consortium 56 MKC# MKC# PP 56 Acute Decompensated Heart Failure 56 Genomics Initiative 55 ACCORD Eye 55 phase IIa clinical 55 multicenter study 55 Digital Mammographic Imaging 55 phase IIb trial 55 #:#-# [007] 55 EnVivo Pharmaceuticals Inc. 55 Electroencephalography 55 NIBR 55 CATIE AD 55 Neurodegenerative Disorders 55 Fibromyalgia Syndrome 55 #:#-#,# [003] 55 Interagency Coordinating Committee 55 Deutscher eV 55 Diabetes Digestive 55 Lung Cancer Screening 55 Sorafenib HCC Assessment 55 Trophos 55 Sequenced Treatment Alternatives 55 multicentre 55 Cell Signalling 55 Autologous Stem Cell Transplantation 55 Coronary Revascularization 55 CALERIE 55 Network NGFN 55 Genetic Markers 55 multicentre study 55 Phytotherapy 55 A. Martinos 55 Autoimmune Diseases 55 multicenter placebo controlled 55 Diabetes Interventions 55 Fabry Disease 55 Physician Scientist 55 Pediatric Imaging 55 Amarantus 55 Serdolect ® 55 OSUCCC 55 EVGN 55 Experimental Therapeutics Program 55 Bart De Strooper 55 WTCCC 55 kidney urologic 55 Therapeutic Targets 55 Phase 1b clinical trials 55 NSABP 55 Immunotherapeutic 55 multicentre prospective 55 Resource Exchange AGRE 55 Large Scale Sequencing 55 Computational Genomics 55 Nanotechnology Characterization Laboratory 55 Biomarker Discovery 55 Molecular Genetic 55 ELCAP 55 TrialNet 55 CT Colonography Trial 55 Neurologic Diseases 55 Professor Francesco Muntoni 55 Nuclear Receptors 55 phase IIb clinical 55 FOLOTYN ® 55 RNA Therapeutics 55 PPMI 55 Genetic Diseases 55 Bipolar Disorders 55 Severe Asthma 55 Translational Biology 55 Hematologic Malignancies 55 Excellence CCNE 55 multicenter randomized Phase III 55 ACOSOG Z# 55 Carotid Revascularization Endarterectomy vs. 55 International HapMap Consortium 55 multicenter 55 Cancer Biomarker 55 Prof. Gozes 55 fosbretabulin 55 MADIT CRT 55 Cutaneous T 55 Wellstat 55 multicenter randomized controlled 55 Kari Hemminki 55 Multicenter Study 55 Dana-Farber/Harvard Cancer Center 55 placebo controlled clinical 55 ALTANA Pharma AG 55 OSUCCC James 55 Confirms Efficacy 55 ASCEND HF 55 Psychedelic Studies MAPS 55 Bowel Project NSABP 55 Agence Nationale de la 55 prospective observational 55 Molecular Epidemiology 55 NIMH Mood 55 Molecular Pharmacology 55 Immunobiology 54 genomewide association study 54 IMiDs ® compound 54 Marrow Transplant Research 54 Patient Oriented 54 Hematological 54 Successfully Completes Phase 54 ENDEAVOR IV 54 BRIM3 54 PsychoGenics 54 Regeneration Medicine 54 psoriatic arthritis PsA 54 Phase IIA 54 Peer Reviewed Medical 54 Research www. elsevier.com 54 Phase III placebo controlled 54 Neurochemistry 54 Thrombosis Research 54 Edge STudy 54 Pulmonary Diseases 54 clinical pharmacology studies 54 PLCO 54 BRAF mutated 54 Group B CALGB 54 RE LY 54 Sapacitabine 54 ASPIRE HIGHER 54 Sansum Diabetes Research 54 Kinase Inhibitors 54 TauRx Therapeutics 54 LUX Lung 54 RE LY ® 54 receptor tyrosine kinase inhibitor 54 Orygen Research 54 Pharmacogenetics 54 TREAT NMD 54 Genetic Disease 54 glucokinase activator 54 Islet Transplantation 54 Institute PCORI 54 Pivotal Trial 54 CTSAs 54 Thoraxcenter Erasmus University 54 Refractory Angina 54 Brain Mapping 54 Neuroprotection 54 Paediatric Endocrinology 54 Randomized Study 54 news subscribe.htm 54 Epidemiological Studies Unit 54 Antibody Therapeutics 54 MD Moross Institute 54 Enrolling Patients 54 multicenter Phase III 54 Phase #b/#a clinical 54 ERATO 54 Trial NLST 54 Raloxifene Evaluation MORE 54 Val HeFT 54 MDRF 54 Ansary Stem Cell 54 Asthma Clinical 54 Preclinical Models 54 Kidney Diseases NIDDK 54 MRC Prion Unit 54 EHT AGN 54 Beta Cell Biology 54 SAEC 54 pralatrexate injection folate analogue 54 Phase III psoriasis 54 Enobia 54 IL# PE#QQR 54 EURIDIS 54 Antithrombotic 54 riociguat 54 Potato Genome Sequencing 54 Biotechnology ICGEB 54 phase IIa 54 Neuromuscular Diseases 54 Hematopathology 54 Experimental Hematology 54 Prostate AdenoCarcinoma Treatment 54 Translational Genomics 54 APEX PD 54 #:#-# [024] 54 MGd 54 CNS Disorders 54 TargeGen 54 HYVET 54 Kidney Disease Education 54 Zosano Pharma 54 Prolongs Survival 54 Laryngeal Cancer 54 M.D. Ph.D. 54 Postdoctoral Fellowship 54 Principle Investigator 54 Circulatory Support 54 Cancer Immunotherapy 54 MDEX Consortium 54 Molecular Carcinogenesis 54 ongoing Phase IIIb 54 Diabetes Endocrine 54 Scripps Genomic Medicine 54 Cardioxyl Pharmaceuticals 54 #:#-#,# Medline 54 www.cancerconsultants.com 54 designated HVTN 54 TRO# 54 Romidepsin 54 blinded randomized placebo controlled 54 Pediatric Psychopharmacology 54 Neurodegenerative 54 Quantitative Biosciences QB3 54 Emerging Infectious Disease 54 Clinical Pharmacy 54 Phase III Clinical Trial 54 Stenting Trial CREST 54 PF # [002] 54 cathepsin K inhibitor 54 Insulin Resistance Atherosclerosis 54 multicenter multinational 54 aripiprazole Abilify 54 GAMMAGARD 54 Prolexys 54 multicenter Phase II 54 RIO Lipids 54 TIMI Study Group 54 Preclinical Study 54 Chemoprevention 54 Research CIHR 54 Behavioral Biology 54 familial amyloidotic polyneuropathy FAP 54 Crit Rev 54 First Patient Enrolled 54 Surgical Treatment 53 Anticancer Drug 53 Molecular Cancer 53 Cancer Genetic Markers 53 Randomized Evaluation 53 VITAL Trial 53 GTC recombinant form 53 Cardiac Arrhythmia 53 Postdoctoral Position 53 BRIM2 53 CARE HF 53 de la Recherche Agronomique 53 Myocardial Infarction TIMI Study 53 Protexia ® 53 Translational Science Institute 53 Genes Identified 53 Phase IIIb 53 Ph.D. D.Sc. 53 pharmacogenomic translational research 53 Pediatric Diabetes 53 Bioanalysis 53 Tibotec BVBA 53 Epiphany Biosciences 53 National Surgical Adjuvant 53 Predoctoral 53 Tanespimycin 53 BCRI 53 Metabolic Disease 53 Wisconsin Sleep Cohort 53 Biodesix 53 NIHR 53 Safinamide 53 Craniofacial Pain 53 Dr. Vassilios Papadopoulos 53 HORIZONS AMI 53 Interstitial Cystitis 53 NCCAM 53 Severe Sepsis 53 Neurorehabilitation 53 Ocrelizumab 53 STRIDE PD 53 Neuromuscular Disorders 53 Complications Trial 53 Prostate Cancer Prevention 53 ARRY # 53 FRSQ 53 multicentre randomized double 53 ExTRACT TIMI 53 Hematological Cancers 53 Digestive Diseases 53 Biological Therapy 53 Investigational Drug 53 J Nutr 53 Tesmilifene 53 Aging NIA 53 randomized controlled Phase 53 Villejuif France 53 Clinical Trials 53 BIIR 53 PhD Studentships 53 Integrative Graduate Education 53 Bayer HealthCare Onyx Pharmaceuticals 53 Nicotine Vaccine 53 Heart Failure Trial 53 Clinic Taussig Cancer 53 Ocular Hypertension Treatment 53 ICON7 53 Molecular Virology 53 Male Infertility 53 CYT# potent vascular disrupting 53 Neurodevelopment 53 NANT 53 PRoFESS 53 Epidemiological Studies 53 AIR CF2 53 AFREZZA TM 53 #:# -# [004] 53 Berlin Buch Germany 53 Outcome Sciences 53 Bioimaging 53 Completes Patient Enrollment 53 Gene Therapy Advisory 53 RTOG 53 Helmholtz Zentrum München 53 Small Molecule 53 CURRENT OASIS 7 53 Genome Sequencing Centers 53 Pancreatic Disease 53 Index SPI SPIEX 53 Translational Molecular Medicine 53 Statistical Genetics 53 NERI 53 Elazer Edelman 53 NeuroScience Canada 53 Cardiac Stem Cell 53 Cloretazine ® 53 Novel Therapeutic 53 Marillion Pharmaceuticals 53 ClinicalTrials.gov 53 Intensive Care Medicine 53 pediatric rheumatology 53 Dermatopathology 53 controlled multicenter 53 Schizophrenia Consortium 53 Immunopharmacology 53 Phase IIIb study 53 deCode genetics 53 plasma protein biotherapeutics 53 Phase Ib Clinical Trial 53 & Rheumatism journal 53 Cytopathology 53 Inherited Disease Research 53 multicenter randomized 53 multicenter clinical 53 Anti Infective 53 Association Française contre 53 Health Research NIHR 53 Quark Pharmaceuticals 53 Nereus Pharmaceuticals 53 Cardiovascular Risk Factors 53 vitro pharmacology 53 Biostatistical 53 immunogenetics 53 Brain Disorders 53 Virion Systems 53 CALGB # [002] 53 Neurological Disease 53 AIM HIGH 53 Artificial Organs 53 SIRO Clinpharm 53 REALITY Trial 53 Phase 2b Clinical Trial 53 de Recherche Clinique 53 Childhood Asthma 53 Sidney Kimmel Cancer 53 ASU Biodesign Institute 53 ERYtech 53 Clinical Guideline 53 Fonds de la recherche 53 Powell Gene Therapy 53 Cancer Genome 53 Myocardial Infarction 53 PORxin TM platforms 53 Psycho Oncology 53 Phase III TRIST 53 CLL8 53 CINtec R 53 EMPHASIS HF trial 53 Replication NCS R 53 Trastuzumab DM1 53 Neuromuscular Research 53 RNAi Therapeutics 53 Relapsing Multiple Sclerosis 53 CEQ# 53 Pharmacogenetics Research 53 Chronic Heart Failure 53 Completes Dosing 53 LIPID MAPS 53 tramiprosate Alzhemed TM 53 Consortium MMRC 53 Genetics Laboratory 53 Investigational Treatment 53 Prospective Multicenter 53 Organizations ACRO 53 Pfizer Ophthalmics 53 Decompensated Heart Failure 53 Biostatistician 53 Cancer Biomarkers 53 Cytometry 53 Receives Orphan Drug Designation 53 Supportive Care 53 Relieve Depression 53 Multi Ethnic Study 53 Initiates Enrollment 53 Nephros Therapeutics 53 Stem Cell Treatment 53 name Biospherics 53 Tom Misteli 53 Advanced Renal Cell 53 See CLINICAL PHARMACOLOGY 53 Astex Therapeutics 53 Coriell Personalized Medicine 53 Cellular Immunology 53 OHRI 53 Mycophenolate Mofetil 53 BioRexis 53 Radiopharmaceutical 53 RNAi Therapeutic 53 Genetic Disorders 53 Trial PCPT 53 NCT# ClinicalTrials.gov 53 registrational Phase 53 placebo controlled multicenter 53 Hsp# Inhibitor 53 SPORE grant 53 randomized Phase III 53 Screening Trial DMIST 53 Wenner Gren Foundation 53 Antibody Discovery 53 SUTENT ® 53 placebo controlled Phase 53 Molecular Basis 53 Proellex TM 53 UM Comprehensive Cancer 53 Aneurysm Repair 53 Manipal Acunova 53 Nutritional Metabolism 53 Antigen Specific 53 Translational Science 53 Human Embryonic Stem 53 Brain Tumor Therapy 53 Genome Quebec 52 Actelion Pharmaceuticals 52 NINDS 52 Pirfenidone 52 Karolinska Institutet Sweden 52 Acute Ischemic Stroke 52 Omnicare Clinical 52 novel VDA molecule 52 Imaging Biomarkers 52 TB Vaccine 52 Postdoctoral Fellowship Program 52 AACR #st Annual Meeting 52 Cerimon 52 somatostatin analog 52 BEZ# 52 UW Madison Waisman 52 bioRASI 52 Clinical Psychopharmacology 52 Phase 2a Clinical Trial 52 NKT Therapeutics 52 acyclovir Lauriad R 52 Jonsson Comprehensive Cancer 52 relapsing remitting MS RRMS 52 Molecular Libraries 52 Sipuleucel T 52 Panacea Pharmaceuticals 52 different sweetener saccharin 52 Biomedical Genomics 52 National Oncologic PET 52 Bioequivalence 52 Immunology NII 52 Sudha Seshadri MD 52 Radiology Imaging Network ACRIN 52 IMiDs R 52 Renal Cell Carcinoma RCC 52 Baltimore Longitudinal Study 52 Cancer Incidence 52 Teva Novopharm 52 ICAEL 52 Bioresearch 52 Randomized Controlled Trials 52 LHON 52 Genomics Consortium 52 Alzheimer disease cognitive impairment 52 Myocardial Infarction Study 52 thorough QTc 52 UCSB Neuroscience 52 INSEEC Schools 52 Phase III randomized 52 phase Ib 52 Teva Provides Update 52 ARUP Laboratories 52 Citicoline 52 Inflammatory Markers 52 NIBIB 52 Hepatocellular Carcinoma HCC 52 Cenix BioScience 52 Cancer Immunotherapeutics 52 Horizon Scanning 52 rivastigmine Exelon 52 Genetic Susceptibility 52 Multicenter Randomized 52 WEB OF SCIENCE 52 GATTEX TM 52 UAEGDA 52 Drug Shows Promise 52 Taussig Cancer Center 52 Ichor Medical Systems 52 Functional Genomics 52 Bone Marrow Transplantation 52 recurrent glioma 52 Communities ARIC Study 52 Randomized Double blind 52 Addiction Psychiatry 52 mGluR2 NAM 52 Metabolic Disorder 52 NIH Vaccine 52 Phase IIIb clinical 52 Systematic Review 52 prospective multicentre 52 Tetrabenazine 52 Phase 1b trial 52 Behavioural Neuroscience 52 Shanghai Medicilon 52 Battelle Biomedical 52 DCCT EDIC 52 HIV AIDS Vaccine Immunology 52 Biochemical Pharmacology 52 Curaxin 52 Jeffrey Modell 52 Interventional Cardiologists 52 Geriatric Cognitive Disorders 52 evaluating Actimmune 52 FLUPAN 52 Group ECOG 52 Monoclonal Antibody 52 Seasonal Influenza Vaccine 52 Treatment Resistant 52 Diamyd ® 52 Inflammatory Diseases 52 Saegis Pharmaceuticals 52 Phase III metastatic melanoma 52 EORTC 52 Dr. Pasinetti 52 Phase IIB 52 Developmental Genetics 52 recurrent metastatic ovarian cancer 52 #:# -# [006] 52 multicenter prospective 52 Initiates Phase III 52 Cognitive Deficits 52 Myocet 52 Kathleen Merikangas 52 Dr. Ayalew Tefferi 52 Phase III Clinical Trials 52 Enzyme Replacement Therapy 52 ToGA 52 Nonalcoholic Fatty Liver Disease 52 Nuon Therapeutics 52 REGENERX BIOPHARMACEUTICALS INC. 52 Welichem 52 Cloretazine 52 NICE SUGAR 52 Pharmacology Toxicology 52 Cardiac Allograft Rejection 52 Pediatric Allergy 52 Pharm Olam International 52 Control Consortium WTCCC 52 congenital toxoplasmosis 52 Neulasta R 52 Collaborative Neuroscience 52 Anti Tumor 52 Cognitive Disorders 52 Neuroimmunology 52 Lipid Lowering Treatment 52 Subgroup Analysis 52 phase III isavuconazole 52 en santé du Québec 52 Cardiotoxicity 52 Phase IIb III 52 randomized controlled multicenter 52 sunitinib malate 52 Mien Chie Hung 52 NDDR 52 KuDOS 52 KM Venkat Narayan 52 Pediatric Gastroenterology 52 NHGRI Large Scale 52 Phase 2b kidney transplant 52 Treat Parkinson Disease 52 Epidemiologic Study 52 Initiates Phase II 52 MADIT 52 Cimzia certolizumab pegol 52 Hospital Acquired Pneumonia 52 infantile colic 52 #:#-#,# [002] 52 Allergy Cardiovascular 52 Destum Partners 52 Meta Analysis 52 Pregnancy Outcomes 52 Investigational Compound 52 SAGE Scholars 52 multicentre randomized controlled 52 Therapeutic Competitors Report 52 Neuro oncology 52 Human Neural Stem 52 Cardiovascular Genetics 52 LCG Bioscience 52 Pancreas Cancer 52 Tumor Response 52 ONCONASE R 52 Gynecological Cancer 52 Aethlon Medical Announces 52 pregabalin Lyrica 52 Allergic Diseases 52 Phase III Pivotal 52 GTC recombinant human 52 Advanced Heart Failure 52 personalized cellular immunotherapy 52 Basic Biomedical Sciences 52 Psychotic Disorders 52 SCD HeFT 52 Shows Promise Against 52 Clinical Physiology 52 Histopathology 52 Bioservices 52 UCLA Neuropsychiatric Institute 52 Hematological Malignancies 52 Clinical Trial 52 Mitochondrial Dysfunction 52 NO# [002] 52 Consejo Superior de Investigaciones 52 Initiates Clinical 52 Quantitative Biosciences 52 PepTcell 52 Human Microbiome Project 52 prospective randomized placebo 52 ACOMPLIA R 52 Ole Isacson 52 Scientific Advisory Boards 52 Orphan Diseases 52 Bioenergy Research 52 HVTN 52 Orphan Status 52 controlled multicenter Phase 52 Multicenter Phase 52 multicenter trials 52 Abstract Accepted 52 blinded placebo controlled 52 Vimpat ® lacosamide 52 PATH Malaria Vaccine Initiative 52 Charles DeCarli 52 Collaborating Centres 52 NSF Integrative Graduate 52 Biological Physics 52 Clinical Evaluation 52 Thurston Arthritis 52 Cardiovascular Diseases 52 ALN HPN 52 Urologic Cancer 52 Liprotamase 52 Observational Study 52 Friedreich Ataxia FRDA 52 PSMA ADC 52 Granted Orphan Drug 52 TEC #OL 52 Translational Oncology 52 Communities ARIC study 52 GW# [003] 52 Pharmaceutics 52 Functional Medicine 52 Multicenter Automatic Defibrillator Implantation 52 Tikvah Therapeutics 52 Geochimica et Cosmochimica Acta 52 Dr. Jose Baselga 52 prospective observational cohort 52 de la Santé et 52 HCV SPRINT 52 Phase 1b clinical 52 PFO migraine 52 Molecular Oncology 52 neurotherapeutics 52 Institute DFCI 52 Nicotine Addiction 52 Islet Transplant 52 HPCGG 52 Genes Involved 52 Blinatumomab 52 DMD DMSc 52 Chicago Multidisciplinary Symposium 52 NIDDK 52 modENCODE 52 Pfizer Regenerative Medicine 52 IIa clinical trials 52 Translational Breast Cancer 52 hereditary medullary thyroid 52 Hepatocellular Carcinoma 52 Acute Treatment 52 RPGEH 52 Dr. Fehlings 52 MEASURE DHS 52 Phase Ib clinical trials 52 Vaccine Adjuvant 52 KINAXO 51 enroller 51 Cooperative Oncology 51 Dupuytren Contracture 51 Platelet Inhibition 51 SPARCL 51 Medicinal Cannabis Research 51 Alpha Tocopherol Beta Carotene 51 Network HVTN 51 Patient Enrolment 51 Arimoclomol 51 Evaluative Clinical Sciences 51 Galenea 51 protein tyrosine phosphatase 1B 51 Genetic Predisposition 51 ID NCT# 51 Cardiovascular Imaging 51 Oral Calcitonin 51 BCR ABL inhibitor 51 Geodon ziprasidone 51 FDA CDER 51 Personalised Medicine 51 pediatric glioma 51 Phase IIb Clinical Trial 51 Genes Discovered 51 Therapeutic Antibodies 51 ANCHOR trial 51 PRECiSE 51 study1 51 FASN 51 OncoVex 51 Neural Repair 51 Novel Vaccine 51 adrenergic regulation 51 Cohort Study MACS 51 Radiation Oncologists 51 Primary Immunodeficiency 51 Cell Transplant 51 GICD 51 Clinical Gerontology 51 Digital Pathology 51 Psychiatry #:#-# [002] 51 Cethrin R 51 Antibody Drug Conjugate 51 LIAI 51 CNS Therapeutics 51 ASTEROID 51 DIRECT Trial 51 Genetic Testing 51 ORWH 51 Combination Treatment 51 Phase III Trial 51 NIAID NIH 51 Human Gene Therapy 51 Postmenopausal Hormone Therapy 51 H. Erich Wichmann 51 Cutaneous Oncology 51 Cannabinor 51 Pediatric Pharmacology 51 Stem Cell Therapies 51 Protein Expression 51 EOquin TM phase 51 CB2 selective receptor agonist 51 REMEDI 51 UCLA Ahmanson Lovelace 51 Bucindolol 51 NSABP B 51 Lung Cancer Drug 51 Traversa Therapeutics 51 ONTARGET R 51 multicentre randomized 51 INSERM Institut 51 lorcaserin Phase 51 Nahum Sonenberg 51 Pregnancy Registry 51 Amplimmune 51 Hedgehog Pathway 51 COPAXONE R 51 Degarelix 51 Clinical Trial Data 51 CCST 51 Randomized Phase II 51 Cellular Therapeutics 51 Gerontological 51 Neuroscience Institute 51 Diabetic Medicine 51 HGS# 51 #:#-# [020] 51 GfK HealthCare 51 RE MODEL 51 Surgeons Oncology 51 Therapy Evaluation 51 brivanib 51 Progenitor Cells 51 Phase Ib study 51 Diesen Winkler Post 51 Arch Neurol 51 Agouron Institute 51 Serious Adverse Events 51 ONCOLOGY